Related Experiment Video

Updated: Jun 30, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Immunogenic Cell Death: Unlocking New Frontiers in Cancer Immunotherapy

Katherine Yaacoub1

  • 1Department of Sciences, Faculty of Natural and Applied Sciences Notre Dame University-Louaize Zouk Mosbeh Lebanon.

Cancer Innovation
|June 29, 2026
PubMed

Insights

Regulated cell death, known as cancer immunotherapy, can be harnessed to fight tumors. Understanding immunogenic cell death (ICD) is key to developing new cancer treatments.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Cell death is a fundamental biological process, with dysregulation linked to diseases like cancer.
  • Cancer immunotherapy leverages the immune system to eliminate tumor cells.
  • Immunogenic Cell Death (ICD) is a programmed cell death pathway that enhances anti-tumor immunity.

Purpose of the Study:

  • To review the mechanisms of Immunogenic Cell Death (ICD).
  • To highlight drugs capable of inducing ICD.
  • To discuss combination strategies for enhanced cancer therapy.

Main Methods:

  • Literature review of scientific articles on ICD.
  • Analysis of drug-induced ICD.
  • Discussion of therapeutic combinations.

Main Results:

  • Perturbations in cell death pathways are implicated in cancer development.
  • ICD induction can enhance tumor immunogenicity and trigger adaptive immune responses.
  • Certain drugs can induce ICD, offering therapeutic potential.

Conclusions:

  • A deeper understanding of ICD mechanisms is crucial for advancing cancer treatment.
  • ICD-inducing drugs represent a promising therapeutic strategy.
  • Combining ICD inducers with other treatments may improve efficacy against various tumors.
Keywords:
cell deathcombination therapiesimmune checkpoint inhibitorsimmunogenic cell deathimmunotherapy

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...